To further access the clinical relevance of CUL5 in cancer, we applied the Tumor Immune Dysfunction and Exclusion (TIDE) analysis to examine the association of CUL5 expression81 with T cell dysfunction and disease outcomes. Here, CUL5 is linked to neoplasm.